Applicant, as named in the Orange Book

Eugia Pharma Speclts

Next listed expiry: Cyclophosphamide on 26 Jun 2035. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Cyclophosphamide · 3 strengths cyclophosphamide	cyclophosphamide	210735	26 Jun 2035	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.